Chimerocyte, Inc.
Doing business as Chimerocyte Inc.
- UEI
- MRUSKCJLLEB7
- CAGE
- 7XPK8
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sttr phase II contract entitled iodide for the treatment of influenza and other stresses | ACC Aberdeen Proving Ground | $1,092,350 | |
| Phase i first monthly report | ACC Aberdeen Proving Ground | $166,498 | |
| Highly sensitive chimerism testing to detect early leukemia relapse post-allo-transplantation | National Cancer Institute | $299,704 |
Quick answers
What is Chimerocyte, Inc.'s UEI?
Chimerocyte, Inc.'s Unique Entity ID (UEI) in SAM.gov is MRUSKCJLLEB7.
What is Chimerocyte, Inc.'s CAGE code?
Chimerocyte, Inc.'s CAGE code is 7XPK8.
What is Chimerocyte, Inc.'s primary NAICS code?
Chimerocyte, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Chimerocyte, Inc. registered in SAM.gov?
Chimerocyte, Inc.'s SAM.gov registration expired on November 12, 2025.
What is Chimerocyte, Inc.'s most recent federal award?
Chimerocyte, Inc.'s most recent federal contract award is Sttr phase II contract entitled iodide for the treatment of influenza and other stresses (W911NF22C0049), from ACC Aberdeen Proving Ground, on September 29, 2022.
On GovTribe
See Chimerocyte, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors